ITEM DEV AB has a total of 29 patent applications. Its first patent ever was published in 1985. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are CATALENT ONTARIO LTD, SHIRE BIOPHARMACEUTICALS HOLDINGS IRELAND LTD and ILTOO PHARMA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 5 | |
#3 | Australia | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Canada | 3 | |
#6 | Sweden | 3 | |
#7 | Germany | 1 | |
#8 | Poland | 1 | |
#9 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Medical purpose containers | |
#4 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Sollevi Alf | 16 |
#2 | Thurell Peter | 10 |
#3 | Thurell P | 2 |
#4 | Peter Turell | 1 |
Publication | Filing date | Title |
---|---|---|
CA2299320A1 | New method of treatment | |
AU2423595A | New method of treatment | |
US5648341A | Method of treating pulmonary inflammation by continuous administration of an adenosine-containing solution | |
AU5401394A | Dispenser for medical preparations and insert therefor | |
US5731296A | Selective vasodilation by continuous adenosine infusion | |
AU660186B2 | Dispenser for medical preparations | |
DE19975044I2 | Use of adenosine for the manufacture of a medicament for continuous intravenous infusion to human patients |